Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Explore effective ways to boost your credit card point accumulation. Learn strategies to earn more rewards with every purchase.
21,988 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Want to put $1,000 into tech without picking individual stocks? This guide recommends a single, low-cost tech ETF, ex...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
When yields rise, even patient investors can feel the pressure. This guide explains what rising treasury yields spook...
As the labor market tightens, some firms are betting on competitive ping pong to boost retention and recruiting. This...
BIT Capital trimmed a large Lemonade stake in the first quarter, revealing how institutional moves can influence vola...
Oil prices stayed contained as Beijing taps strategic stockpiles, a trend analysts say explains why crude hasn’t surg...
In 2026, some AI-related players outshined Nvidia, delivering eye-popping gains and signaling a broader AI infrastruc...
More than 160 former national security, intelligence, and law enforcement officials are urging the Senate to move for...
Turnaround stories can create powerful upside for patient investors, but they also open doors for short sellers who b...
SpaceX headlines are loud, but IPOs are not always friendly to investors. This article outlines seven solid reasons a...
Choosing the right healthcare ETF in 2026 hinges on costs, diversification, and your risk tolerance. This analysis pi...